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In this lecture I want to address
myself to the questions: What is the
lowest oxygen tension compatible
with adequate function, and what
are the factors that set this limit?
Much of the background to the
material presented here has been
reviewed extensively in the not too
distant past (JObsis '64), and I
will take the liberty of letting that
article provide most of the detailed
justification of my remarks today.

I. Mechanisms of Oxygen
Utilization
In mammals there are three
mechanisms for the utilization of
dissolved oxygen. First, I will list
these, and then I will emphasize the
last one of these, since it accounts
for the major part, by far, of the
oxygen uptake in the body. These
three are:
A. Oxygen trans/erases
for which the generalized reaction can be written
A+ 0 2 ~ A02
in which A is a substrate that
accepts two separate oxygen atoms;
B. Mixed function oxidases
with the reaction
AH+ 2e- +

o.~ AOH

+

o=

(~H20)

where the last notation signifies the rapid final step of water
production from o= and 2H+ ions;

* Supported in part by Grant NB
06729 from the National Institutes of
Health.
tPresented at the Symposium on
Intracellular pH, PCO., and PO,, September 29, 1967, Medical College of
Virginia, Richmond.
MCV QUARTERLY 3(4): 169-188, 1967

C. Electron transfer oxidases
catalyzing the reaction
4e- + 02 ~20= (~2H,O)
Numbers one and two are mainly
active in the catalytic oxidation of
amino acids and of some steroids
and account at most for 1 % of
the total 02 consumption in mammals. They are, therefore, of very
little importance to us in this
symposium.
The enzyme systems catalyzing
the last category can be subdivided
into, firstly, autoxidative flavoproteins and, secondly, the respiratory
chain.
1. The oxidation of autoxidative flavoproteins can be written
flavinH, + 0 2 ~ flavin + H.O.
The hydrogen peroxide formed is
removed by the action of catalase.
These reactions may account for
about 10% of the total oxygen uptake in the body. We are not too
sure where this uptake takes place
or even what subdivision of the cell
is the site of this oxygen consumption. One of the few known variables affecting this reaction is acclimation. Russian workers have
shown that, during hibernation,
the fraction mediated by the autoxidative flavoproteins goes from
10% to approximately 25 % (Skulachev, 1962). Another important
fact is that no mechanism has been
found by which energy conservation takes place in this reaction.
More specifically, no high energy
phosphate production has been
found associated w ith this reaction.
2. The respiratory chain accounts for all the rest of the oxygen
taken up by the tissues. This is the
mitochondrial contribution to overall oxidative metabolism. A system

of redox couples catalyzes the transfer of reducing equivalents from the
substrates to oxygen and results in
the formation of water. This is
shown in Figure 1 together with
some of the inhibitors and side
reactions of the respiratory chain.
In the respiratory chain three locations, identified by asterisks in
the above scheme, contribute to the
overall process by being loci for
the conservation of energy in the
form of high-energy phosphate
bonds (-P) that are transferred to
adenosine diphosphate (ADP) to
form adenosine triphosphate
(ATP). The reaction, which is referred to as oxidative phosphorylation, is obligatorily coupled to the
electron transfer steps in the chain.
This coupling produces an effective
control mechanism for the rate of
oxygen uptake. If no ADP is available, no oxidative phosphorylation
can take place, and electron transport is slowed down dramatically.
This gives rise to the difference in
rates of O, consumption during
rest and during strenuous exercise.
Failure of oxidative phosphorylation to take place is the main harm
associated with anoxia. The respiratory chain plus its side reaction,
oxidative phosphorylation, is, therefore, the reaction system that must
be understood for any discussion
of critical O, levels. I would like to
discuss these processes now.
Starting at the substrate side of
the respiratory chain, we enter
with certain substrates and their
dehydrogenases which will reduce
NAD+ to form NADH (nicotinamide-adenine di nucleotide). [The
old-fashioned name was DNP, and
many people still refer to it as
DPN+ and DPNH]. NADH is able
169

OXYGEN TENSION

to reduce flavoproteins and, then,
from there, follow a set of redox
couples, each one oxidizing its predecessor by electron transfer and being oxidized by the next one until O,
is reached. This is a set of cytochromes identified by letters, i.e.,
cytochrome b, cytochrome c,, cytochrome c, cytochrome a and cytochrome a,. Potential differences between the numbers of the respiratory chain are neatly arranged along
the line so that electron transfer
proceeds naturally toward o•.
At three locations, the potential
energy of the overall reactionwhich in the end is really the reaction of hydrogen in the substrate
with oxygen to form H.O- this
potential energy of burning up the
substrate is saved. In these three
spots, reactions take place resulting
in the formation of ATP from ADP
and inorganic phosphate. There are
three of these sites, and three P
moieties are formed per oxygen
atom. However, there are certain
substrates, such as succinate, that
are oxidized without benefit of
NAD , and their oxidation only
yields 2,_, P, since the site between
NAD and flavoprotein is Jost.
These two functions, electron
transfer and high energy phosphate
production, are very tightly coupled.
They are obligatorily linked. Without the one the other does not take

ma late

place, unless something is amiss.
This brings with it some very important corollaries. For instance,
if there is not enough ADP near the
mitochondria, oxygen uptake comes
to a halt, because partial blocks
occur at three steps. This is referred
to as respiratory control. In the
same vein, the absence of electron
acceptor (02) results in stoppage of
electron transfer and, therefore, no
further oxidative phosphorylation
takes place. This is the fatal outcome of asphyxiation.
II. Main Phases of Foodstuff
Degradation
After this very rapid introduction, I would like to discuss some of
these points more quantitatively
and emphasize the methods that
are available for the study of the
respiratory chain. I think this is
very important, and I am glad that
Professor Patterson emphasized
your interest in methods. Without
an understanding of the methods,
we really don't have a thorough
understanding of the reliability of
a scientific assertion, especially at
the level of complexity that we
meet in biology. Therefore, I will
emphasize the methods as we go
along.
Starting then on the substrate
side, Table 1 summarizes the re-
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actions between the ingestion of
food and the form in which it
enters the Krebs cycle. The table is
adapted from Krebs and Kornberg
(1957) and speaks further for itself. What occurs is a rather amazing simplification of a great variety
of compounds. The cell modifies
and simplifies these complex substances into a rather small number
of intermediates. Thus, we end up
with acetyl coenzyme A and a few
other things such as a-ketoglutaryl
and oxaloacetic acid. In the third
phase these three feed into the citric
acid cycle, and there decarboxylation and dehydrogenation take
place. This, of course, is the important step; this is where NADH
is being formed. I always like to
think of decarboxylation as just
getting rid of the carbons. No energetically advantageous steps are involved in it. The carbons can be
looked upon as nothing more than
vehicles for carrying hydrogens
around the citric acid cycle for the
reduction of NAD and fiavoproteins.
In Table 2 I have taken these
same four phases and emphasized
the high energy yield per carbon
atom. It is very straightforward for
carbohydrates: 6.4,_, P per carbon.
It is a bit arbitrary for fats, because they differ so much in chain
length. I have chosen palmitate as

'

:

* cyt . c 1 ~ cyt.c ;.::==:: cyt.a
* ;.::==:: cyt . a~ o,
r=:::=
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3

0

Fig. 1-The respiratory chain. The asterisks indicate the probable locations of the phosphorylative steps. The dashed lines
illustrate the point of action of inhibitors blocking the transfer of electrons to oxygen. (BAL: British Anti-Lewisite; HOQNO:
a-hydroxy quinoline N-oxime.) (Reprinted with permission from Handbook of Physiology, Ji:ibsis, 1964.)
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TABLE 1
The four main phases of foodstuff degradation
Outline of Chemical Change

Phase

I

carbohydrates

proteins

fats

l

l

l

about 20 amino acids

hexoses

hexoses

II

glycerol

l

lactic
acid

I

j

several
amino acids
(alanine,
serine,
cysteine)

fatty
acids

I

several
amino acids

several
amino acids
(glutamic
acid,
histidine,
prolines,
arginine)

"~"·~.

tyrosine,
6
phenylalanine)

oxaloacetic
acid

oxaloacetic acid

a-ketoglutaric a cid

decarboxylation
and
dehydrogenation

J

I

L

dehydrogenation,
decarboxylation,
deamination and
shortening of the
carbon chain

1

l

l

acetyl coenzyme A

several
amino acids
(aspartic acid;
tyrosine,
phenylalanine)

a-ketoglutaric acid '

acetyl coenzyme A
III

depolymerization

glycerol; fatty acids

_J

pyruvic acid

Primary Reactions

I

·

l

citric acid .cycle
~·

l

l

IV

L

H20 production

flavin-H2

NADH

I

respiratory chain

TABLE 2
Location, products and profits of the four main phases of foodstuff degradation

R educing Equivalents

Phase

Primary

Chemical Change

Waste

Location

~P Yield
Per Carbon Atom

Products

Yield

Destination

CarOOhydrates

Fats
I -

D e polymerization

None

None

D eh ydrogenation,
Cytoplasmic and
d ecarboxylation ,
intramitochondeamination, and
d r ia l
shorte ning of the
carbon chain

NH3 and urea;
small amounts of
C O , and H ,O

Small amounts of
NADH and
flavin-H2

Used in
IV

0. 33

- o.o6

III

Decarboxylation
and d ehydrogena tion

Intramitochondrial
fluid pha se

co,

Large increase in
NADH and
flavin-H2; small
increase in
NADPH

Used in
IV

0.33

0 .50

IV

H20 production

Mitochondria l
membra nes

H20

La rge decrease in
NADH and
flavin-H2

5 .7o

8.oo

I

Extracellular and
cytoplasmic

None

None

--II

I
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an example. The longer the chain,
the higher your net yield, since you
have to pay a standard price in activation no matter how long the
chain. I have not even attempted
to calculate a similar number for
amino acids; they are too dissimilar.
Note that, in the first stage, there
is no yield of high energy phosphates. In the second stage there is
a very small yield, and actually there
is utilization of high energy phosphates in fatty acid metabolism.
There is an extremely small provision by so-called substrate level
phosphorylations in the third phase,
the citric acid cycle level. In the
fourth or final phase, however, the
great bulk of high energy phosphates arises. In other words, the
most important yield derives from
the last phase, and it is mediated by
the respiratory chain.
It is simple enough to measure
these reactions in a vessel, a manometric one if you need to know the
amount 0, consumed. It is more
meaningful, however, to study the
system in the intact, circulated tissue rather than with slices or iso-

lated mitochondria. It is here that
special instrumental methods are
needed. Almost without exception
such methods have been pioneered
since 1946 by Dr. Britton Chance
at the Johnson Foundation, Departments of Biophysics and Physical
Biochemistry of the University of
Pennsylvania.
Ill. Split-Beam
Spectrophotometric Method
The great boon in the study of
the respiratory chain, and actually
the factor upon which the discovery of the cytochromes hinged,
is the fact that each of the members has optical activity: they absorb light at specific wavelengths.
In the 1920's, Professor Keilin first
described the series of components
that is now known as the cytochrome chain (Keilin, 1925). Although he drew some strong inferences regarding its function, he
did not know, at that time, that
energy was being conserved in conjunction with the cytochrome activity. That had to wait until the

Tun9sten or·

f:\ hi9h pressure
\ J HQ arc lamp

=

Synchronized Chart
with linear wovelenoth scale

Optic al

Density

Fig. 2-The split-beam, difference spectrophotometer. The difference in light
intensity emerging from the two sample cells is logarithmically recorded on a
chart directly coupled with the wavelength drive of the monochromator. The
resulting graph is a recording of the difference in optical density at the various
wavelengths. (Reprinted with permission from M ethods in Enzymology,
Chance, 1957.)
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late 1930's. All of his conclusions
were the result of visual spectroscopy. Nowadays we use spectrophotometry to do the same thing.
In this approach one first needs to
determine the identity and the concentration of different components.
For this purpose a special type of
spectrophotometer, the so-called
"split-beam," is used. It is especially
designed for highly light-scattering
preparations such as mitochondria
suspended in a solution or intact
tissue. The instrument is shown in
Figure 2. Starting from the light
source, the beam is diffracted in a
monochromator and is alternately
deflected by means of an oscillating mirror through two cuvettes
placed side by side. One of these is
the sample; the other serves as the
reference. The light emerging from
these two cuvettes is measured by
a photomultiplier. There is a bit
of electronic circuitry concerned
with unscrambling the pulses so
that one can keep track of the light
absorption of the sample as compared with the reference cell. After
subtraction, the difference is recorded logarithmically. This renders the data directly in OD units
which are proportional to concentrations. The monochromator
sweeps through the wavelengths
from about 650 m,u, which is the
dark red, to about 300 mµ. in the
very near UV. The differences in
absorption are recorded on a wavelength scale. Starting with two suspensions of isolated mitochondria,
for example, the first run provides a
base line, since one started out with
equal samples. After an experimental manipulation, for instance
the removal of oxygen, one sweeps
through again, and the difference
between the oxidized and the reduced materials is now recorded.
Figure 3 shows two absolute spectra and their difference spectrum,
using hemoglobin as an example.
The absorption spectrum of hemoglobin in the oxygenated form is
shown by the solid curve, in the
disoxygenated form by the broken
curve. These are absolute spectra;
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but if one puts a disoxygenated sample of hemoglobin in the sample
cuvette and oxygenated hemoglobin
in the reference cuvette, the resulting curve is a difference spectrum,
as shown in the upper part of Figure 3.

Studies on Mitochondria

The same thing can be done for
the respiratory chain in the mitochondria. Mitochondria are obtained from the cells by grinding
and differential centrifugation. They
are suspended in an appropriate
medium and aliquots are pipetted
into the two cuvettes. The spectrum
in the top of Figure 4 shows the
differences in OD between oxygenated and anoxic mitochondria.
The latter were on the sample side;
the former served as reference. The
location of the peaks identifies the
components; the height of the peaks,
the concentration. Reduced cytochromes and NADH have absorption bands that are sharper and
more intense than those of the
oxidized form . Therefore, the peaks
are in the upward direction. The
cytochromes produce a complex of
beta bands which are rather indefinable and are grouped together.
Note that the large trough at 465
mµ. is related to flavoprotein reduction; in contrast with the cytochromes, the flavoproteins absorb
more strongly in the oxidized form.

spectrum of Figure 4. With some
minor differences it is much the
same as the spectrum of the isolated mitochondria. So it is possible
to make these observations and
measure the concentrations in intact tissues. For a physiologist that
is reality. Now we can use the
level of reduction as an indicator
system. For Professor Keilin it was
the beginning. After his visual observations of the cytochrome bands
in intact cells, he was obliged to
isolate and identify the compounds
giving rise to them. Some thirty
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years later Dr. Chance was able to
quantitate the observation in tissues with his new instrumentation.
Nowadays it is not too difficult to
make identifications and measure
concentrations in most any tissue
that interests you.
Reduction Level of Metabolic
States

Since we now have a method
for following changes in oxidation
and reduction of the members
of the respiratory chain, the ques-
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Studies on Muscle

Since I am a physiologist, I consider it important to show that this
is not a biochemist's artifact; that
it is possible to measure the cytochrome absorption peaks in whole
cells also. One does this by taking
two pieces of tissue, for instance,
two muscles carefully dissected, one
from the left leg and one from the
right leg, and measuring the difference spectrum between the
anoxic sample and the oxygenated
reference. The result is the lower
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Fig. 3-Absolute spectra of oxygenated (solid line, bottom) and disoxygenated
hemoglobin (broken line) and their difference spectrum (top).
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tion of their reduction level in
different metabolic states can be
tackled. Not that we are so very interested in the cytochromes per se,
but they serve as indicators of
changes in the rate of oxygen uptake. For example, 0 2 uptake will
be slow when ADP is lacking in a
suspension of mitochondria otherwise supplied with all the needs for
oxidative phosphorylation (i.e., 0 2,
inorganic phosphate and oxidizable
substrates) . Addition of ADP will
then produce a rapid uptake of
oxygen, which will slow down again
when all the ADP has been turned
into ATP. This can be followed
very easily with an oxygen polarograph, an "oxygen electrode." This
is the ideal experiment for determining what happens to the reduction states of the members of the
respiratory chain when oxidative
metabolism changes, as I will show
in just one minute. Concomitantly
with the O., substrate, ADP and
inorganic phosphate will disappear.
A measure of the efficiency of phosphorylation is the well-known P to
0 ratio, i.e., the ratio of the amount
of inorganic phosphate that disappears to the number of oxygen
atoms utilized. For an NADHlinked substrate it is 3; for a flavoprotein substrate it is 2; when the
entire Krebs cycle is operating, we
get an intermediate value, say, 2.5
to 2.7.
Such measurements are possible
with mitochondria in a cuvette, but
not in intact cells. What is possible,
however, is the monitoring of the
optical density changes related to
reduction level changes of the cytochromes. These absorption effects
were first measured in isolated
mitochondria and were found to
be very specific as we do the ADP
addition experiment. For this we
use a slightly different spectrophotometer. The first one I described can only be used for steady
states when we are identifying
components or looking for concentrations. Now we need to follow
changes in absorption over a limited
time span.
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system is needed, because the suspensions (and the tissues as well)
are turbid. What is more, the light
scattering is greatly affected by all
sorts of metabolic reactions. When
light-scattering changes take place,
they are indistinguishable from absorption changes. Both result in
changes in photomultiplier current,
because light is lost. However, it is
lost equally, at first approximation,
from the reference and measuring
wavelengths. Therefore, changes in
the difference between the two
beams are significant, not the total
signal. Total signal changes 20

IV. Double-Beam
Spectrophotometric Method
For this purpose Dr. Chance developed the so-called "double-beam"
spectrophotometer (Fig. 5). A single light source is used for two
monochromators. One is set for the
wavelength of an absorption peak,
the other at an indifferent wavelength to serve as a reference beam.
The two beams are alternately
switched by a vibrating mirror, proceed through the sample, and the
emerging light is measured by an
end-window photomultiplier. This
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Fig. 4-Difference spectra of the respiratory chain. Sample: reduced by anoxia;
reference: in the presence of oxygen. Upper curve: two aliquots of suspended
mitochondria isolated from rat liver [anoxic (state 5) minus starved (state 2)].
Lower curve: two excised toad sartorius muscles [anoxic (state 5) minus resting
with endogenous substrates (state 1)]. (Reprinted with permission from Handbook of Physiology and J. Gen. Physiol., JObsis, 1963 and 1964.)
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times greater than the true absorption changes can thus be tolerated.

Studies on Mitochondria
If we follow the absorption of
one of these cytochromes as we go
through some of the more obvious
metabolic conditions, we will see a
characteristic pattern emerge (Fig.
6). At 430 - 400 m,u, cytochrome
b is monitored. As the mitochondria
come out of the c~ntrifuge tube and
are put in a cuvette, we start the
trace. Now we add ADP, and a decreasing absorption at 430 m,u compared to 400 m,u, signifies that an
oxidation of cytochrome b takes
place. This is inevitable. Substrates
have not been added . The ADPstimulated, high rate of 0 2 uptake
soon exhausts the endogenous substrate supply of the mitochondria,
and cytochrome b goes fully oxidized. At this point .,B-hydroxybutyrate is added, NAD is reduced:
we see a change towards a higher
level of reduction. A plateau is
maintained for a short while; then
another change occurs. Concomitant biochemical determinations
will show that at this point the ADP
that was added has now been phosphorylated to ATP. Electron transfer slows down, and a more reduced state results because of the
blocking of the respiratory chain
further down, close to oxygen. Reducing equivalents accumulate,
therefore, in cytochrome b. When
oxygen uptake is stimulated again
by a new addition of ADP, cytochrome b returns to the previous,
more oxidized state while ATP is
being formed. After a number of
such cycles, all the oxygen is used
up, and an extremely large change
will indicate that b goes completely
reduced. Very much the same thing
occurs for NADH, as is shown in
the right-hand record of Figure 6.
These steady-state changes are
the important ones for our attempts
to measure metabolic rates in the
whole cell- especially this last
transition to full reduction when the
PO. is inadequate. It provides the

"'

Fig. 5-The double-beam, difference spectrophotometer. The difference in light
absorption of two beams of different wavelengths are recorded as a function of
time. The resulting graph shows the kinetics of the wavelength-specific absorption changes; for instance, after the addition of a reactant. (Reprinted with permission from M ethods in Enzymology, Chance, 1957.)
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Fig. 6- 0xidation-reduction levels of cytochrome b and NADH1 in suspensions:
of rat liver mitochondria in states 1 to 4. Note the reduction that occurs after
addition of NAD-dependent substrate (tJ-hydroxybutyrate) and the return from
the state - 4 to the state - 3 level upon the last ADP addition. (Reprinted with
permission from Handbook of Physiology, JObsis, 1964, adapted from /. Biol.
Chem. , Chance and Williams, 1955.)
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signal to determine the critical level
of oxygen needed for the cell. In
Table 3 the metabolic states are
listed as they were defined in the
original article of Chance and Williams in 1955. The numbers of the
states correspond to those along the
traces in Figure 6.

in state 3 than in state 4. It depends on the tissue from which the
mitochondria were prepared and
on the type of substrate furnished.
The important conclusion is that
steady-state changes in the respiratory chain components can be
demonstrated in intact tissues when
the rate of o. consumption changes.

filter between the photomultiplier
and the tissue screens out the reflected 366 mp. light. In addition to
being simpler, the method is also
more sensitive than the spectrophotometric one. This is shown in
Figure 1, which shows the response
to a single twitch. Note that the
spectrophotometric cycles of Figure
8 were the responses to 30 twitches.
Since this figure was published,
further improvements have been
made, so that now a response of the
size shown in Figure 8 shows practically no noise. I have actually
performed experiments with a reproducibility within 2% for a
dozen single twitches over a period
of three or four hours.

Studies on Muscle
Showing again my bias as a
physiologist, I do want to emphasize that these changes do not only
occur in mitochondria in a cuvette,
but can also be seen in muscles.
The same double-beam system can
be used. Light of two wavelengths
shines alternately through a muscle
in the resting metabolic state. This
provides the base line for the experiment (Fig. 7). A number of
rapid twitches are induced, ATP is
hydrolyzed to ADP and recovery
metabolism starts. All the optical
changes of Figure 7 are in complete
accord with the notion that we are
observing the switch to rapid metabolism (state 4 to state 3). When
the ATP has been rephosphorylated, metabolism slows down and
the optical density returns to that
of the resting state. NADH and
cytochrome b went through a cycle
of increased oxidation; cytochrome
c went more reduced. The difference between c in the muscle and
the effect listed in Table 3 is not significant. Since 1955 it has been
shown that c can be more reduced

V. Fluorometric Method

Studies on Toad Sartorius Muscle
In addition to spectrophotometry,
fluorometric observation of NADH
is also possible and has great advantages, especially in tissues with
intact blood supply. This method
rests on the fact that reduced NAD
fluoresces when illuminated with
light near its absorption peak at 340
mµ,. It then emits light with a broad
maximum at about 450 mµ,: a
bluish cast comes from the tissue.
Not all of it is derived from
NADH, but a large part is. Since
the oxidized form (NAD+) does
not fluoresce, we now have another
optical measure of the reduction
state of NAD.
This method is actually simpler.
The intensity of the fluorescent light
is measured with a photomultiplier.
The same surface that is exposed to
the excitation light (usually the
366 mµ, line of a high pressure
mercury arc) is used for observation. An appropriate secondary

Studies on Tissue In Vivo
However, we need to know about
the whole tissue, the intact tissue in
vivo. Excised tissue is only one step
in that direction. Now that there is
a method available for looking at
the surface of tissues and saying
something about the reduction of
NAD, we can apply it to tissues
with intact circulation. For observation we can use any exposed tissue,
in our case, most significantly, the
cerebral cortex. The apparatus is
relatively simple. A microscope
with an epi-illumination system
looks down on the cerebral cortex.
Light from an arc lamp is made to
emerge as a cone around the objective of the microscope and is

TABLE 3

Metabolic states of mitochondria and associated oxidation-reduction levels of respiratory enzymes
Characteristics

Steady-State Percentage Reduction of Components
J

State

1
2

3
4
5

[0.l

ADP

level

Substrate
level

Respiration
rate

>o
>o
>o

Low
High
High

High

Slow
Slow
Fast

>o

Low
High

High
High

0

0

Low
~o

Slow

Rate-limitfug
substance

ADP
Substrate
Respiratory
chain
ADP
Oxygen

a

b

c

--- ---

Flavoprotein•

NADH1

7
0

17
0

21

0

0

0

4

6

16

20

53

0

0
~100

1_4
~100

~go

35

40

99

~ 100

l"":"-'100

~100

These values are based on the amount of flavoprotein of the respiratory chain. Other fractions, reduced by anoxia, are
present but disregarded here. [After Chance & Williams]
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focussed on the observed spot.
Emitted fluorescence, as well as reflected excitation light, enters the
objective lens and goes up the. tube.
The latter is filtered out so that only
the fluorescence light remains.
Much of it, but certainly not all, is
that derived from NADH. A photomultiplier measures the light intensity at the level of the ocular.

340-374 mµ Log
DPNH oxidized

~

lo/I :0.()()2

f

30 twitches in 10 seconds
430-410mµ Loglo/'1=0002
cytochrome b oxidized

f

I

Minimal 0 , Requirement of the
Brain

This instrumentation enables us
to evaluate the minimal 02 requirements of the brain. The first type
of experiment to do is the administration to the animal of gas mixtures
low in 0 2. The type of effect we
look for is an increase in fluorescence, signalling that in some parts
of the tissue the respiratory chain
is not furnished with 0 2 and NAD•
goes to NADH. Such an experiment
on the kidney and brain of the rat
is shown in Figure 9. The animal
is switched from air to 100% N 2
or to 3% 02 in N 2 • This results in
a rise in the fluorescence, indicated
by the downward excursion of the
trace in Figure 9. I apologize sincerely for the change in direction.
Dr. Chance and I have always been
opposed in our views about how to
display this, so I am afraid you will
have to switch back and forth
between the experiments that we
did together and the ones that I did
myself. In his case, an increase in
fluorescence is downward, and in
my case an increase in fluorescence is upward.
As expected, an increase in fluorescence accompanies anoxia. Addition of sulfide also increases fluorescence since it blocks the chain at
the level of cytochrome a,.. All other
components of the chain, including
NAD, become reduced. The same
thing can be shown for cyanide and
CO; they all block at the level of a,.
Amytal will also produce increased
fluorescence by blocking the chain,
this time, however, by inhibiting
the flavoproteins oxidizing NADH.
T hese maneuvers with anoxia (or
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Fig. 7-Steady-state changes of DPNH (NADH), cytochrome b and cytochrome
c in toad sartorius muscles during oxidative recovery from contractile activity.
The vertical ordinates are one minute apart. (Reprinted with permission from
J. Gen. Physiol., JObsis, 1963.)

determine the level of 0 2 necessary for the tissue? It has been my
experience that most of us tend to
look immediately toward the parameters of circulation, the source
of the 0 2, such as hemoglobin, PO,,
blood flow, A-V differences, etc.
However, although terribly relevant, there is a more basic aspect.
That is the question: What limits
the rate of 0 2 uptake when P02
does not?

hypoxia) and various inhibitors
show that the instrumentation does
perform in the intact tissue as
hoped for.
Limiting Factors in 0 , Uptake

Now we should stop for a
moment and reflect on the exact
question of the day. We are asking: What are the parameters that
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Fig. 8-Fluorescence cycle induced by an isometric twitch. Toad sartorius muscle. A decrease in NADH concentration would be registered in a downward
direction. (Reprinted with permission from J. Gen. Physiol., JObsis and Duffield,
1967.)
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Studies on Cells

First we should discuss what happens in intact cells. We can measure the rate of oxygen uptake as
a function of the partial pressure of
oxygen in the cuvette. Diffusion
problems from the blood vessels to
the cells are sidestepped. In Figure
10 we see such an experiment for
yeast cells. The same thing has been
done wi th other cells. It is im-

portant to obtain a good measurement of the P02 at which the rate
of oxygen uptake is decreased. It is
immediately obvious from the two
sets of experiments that the presence of glucose makes an enormous
difference on both the rate of oxygen uptake and the P02 at which the
plateau rate starts to fall. The important point is that in the absence
of glucose, the availability of substrate was the limiting factor long

Rot Brain
Rot Kidney

100% - + - 30/o
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Fig. 9- Fluorescence changes induced by anoxia or severe hypoxia and by sulfide (an electron flow inhibitor) in the kidney and brain of rats. The top line
shows the periods during which different gases were respired. An increase in
NADH concentration would be registered in a downward direction. (Reprinted
with permission from Science, Chance et al., 1962.)
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before the P02. Succinate, although
metabolized rapidly, penetrates
slowly and thus provides only inadequate substrate levels in the
cells. Those experiments were,
therefore, run in a semi-starved
condition. The PO, at which the
two systems begin to show signs
of being limited by o. availability
are 2.5 and 0.21 mm Hg. This tenfold difference is the result of the
difference in rate of metabolism
due to substrate limitations. When
you ask me what the limiting level
of 0 2 is, I will have to ask you,
first, what the rate of respiration is
in terms of total capacity and, then,
what is limiting the rate? Because it
could also quite well be that the
limit is not the substrate but the
blocks accompanying a decreased
demand for oxidative phosphorylation .. The effects of these two causes
of a less than maximal rate will be
slightly different, but, for the moment, that is of secondary importance.
One can make a rather complete
mathematical description of the respiratory chain system, if that is
necessary and useful. Then one can
calculate a number of constants,
such as the apparent Km for 0, ;
extrapolate the data to infinite concentrations of 0 ., substrate, ADP
and inorganic phosphate; and
finally come out with a limiting
value for P0 2 near the mitochondria. I have done my homework on
this and the calculated, "corrected"
curves are shown as broken lines
in Figure 11. In this way I obtained
values of approximately 0.5 mm
Hg (l,uM0 2) for 50 % inhibition
and 5 mm H g (9,uMO.) for a 10%
loss in 0 2 uptake. However, the
numbers have little meaning except
as upper limits. Any time the rate
of 0 2 uptake is not maximal, these
minimal levels will be considerably
lower; in the case of nearly starved
yeast, perhaps 25 times.
The figures above are for conditions in which the respiratory chain
is the only limiting factor. However, as I said, that is hardly ever
the case. Usually the system is
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limited either by the rate of oxidative phosphorylation or by the
substrate supply. This is difficult to
distinguish. It turns out that the resting metabolism of most cells-at
least the ones that we have looked
at-is not limited by a lack of ADP
only. During resting respiration
they do not have fully reduced
levels of mitochondrial NAD such
as isolated mitochondria have.
There is also a subtle but very
effective control of the substrate
level. In resting metabolism the
substrates are not present in excess.
So there must be at least one other
control step, but most likely there
are several. We do not really know
where they are located except that
they are not in the respiratory
chain. This type of control operates
only in the intact cell, not in isolated mitochondria. In all tissues
that we have studied there is this
very definite limit of substrate provision. This limitation is overcome
immediately upon initiation of
more active oxygen uptake. In
other words, there is a multipronged control system of overall
oxidative metabolism. Physiological
activity produces an increase in
oxygen uptake and oxidative phosphorylation by an increase in ADP,
but at the same time it spurs substrate provision. It certainly can do
so by increased glycolysis. This results in an increased availability of
pyruvate for the citric acid cycle.
Apparently there are similar controls in the other pathways feeding
into the Krebs cycle. Of course,
there is an absolute necessity for
meeting the increased needs. Happily, in an experiment it is often
possible to get around this problem
by increasing the substrates from
the outside.
Dr. Patterson: Could you define for
some of us the K m02?
Dr. Jobsis: My apologies. The
shorthand stands for the Michaelis
constant for oxygen.
Let me define it very pragmatically. If one does a plot of the rate
of oxygen uptake as a function of
the P02, one comes up, as I showed

with a curve which looks something
like those in Figure 10. It is useful
to talk about that level of oxygen
where the rate is 50 % of the maximal rate. It is often referred to as
the apparent Km. When I was quoting numbers for the K mo2, I was
talking about the more theoretical
system, i.e., when one would
have provided all conditions so that
only the respiratory chain was limiting. The higher the rate of 0 2 uptake in the experiment, the closer
one is approaching the true K mthe real point of reference for the

respiratory chain as an enzyme system.
Question: Is this the Michaelis formulation applied to your system?
Dr. Jobsis: Yes, but, of course, it
is only a pragmatic constant. A
midpoint or 50 % point is
usually better defined than a "perceptible decrease." Therefore, I
often like to use the experimental,
the apparent Km0 2 •
Question: Wouldn't it be a P02,
then, corresponding to that 5 µ.M?
Dr. Jobsis: No. The K m number is
0.5 mm Hg or lµ.MO ,. One can
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Fig. 11- The rate of oxygen consumption as a function of 0 2 concentration for
ascites tumor cells (curve 1, 37°C), liver cells (curve 2, 40°C), and isolated
liver mitochondria (curve 3, 20°C). The maximal rate observed experimentally
(solid lines) is given the value 100. The upper curves (dashed lines) were calculated after extrapolation of the experimental data in the hypoxic range to infinite
0 2 concentration by a Lineweaver-Burk plot. The lines on the right-hand margin
indicate the theoretically achievable maximal rate unlimited by the supply of
reducing equivalents. (Reprinted with permission from Handbook of Physiology,
JObsis, 1964.)
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use about 10 times that level as a
lower limit for p lentiful 0 2, i.e., 5
mm Hg or about 9µ,M. That is an
average for 10 % decrease in O,
uptake rate, as shown in Figure 11.
I'm not very interested in that number, however, because it's a nonphysiological one. It is calculated
for the system when the respiratory
chain is the only limiting situation,
and that is hardly ever the case, if
ever.
Question: Micromoles per what?
Dr. Jobsis: Micromolar-i.e. , micromoles per liter of fluid .
Studies on Animals
In the physiological case the
number of interest is, of course, the
one for that undefined condition
when substrate is partially limiting.
We would have to make some
really awful generalizations to define it. In addition we would have
to tackle the job of calculating the
PO, midway between capillaries
from blood flow and blood content
data. There are too many badly
known parameters to inspire real
confidence. Instead we can use the
experimental approach that is made
possible by our ability to determine
the adequacy of the P02 by observing the respiratory chain directly.
We will find that PO, in the inspired air at which we first see
NAD going reduced.
What Chance and his co-workers
did was to combine a double-beam
reflection spectrophotometer with
a fluorometer, both of them looking
at the same spot on the cerebral
cortex (Chance, Schoener and
Schindler, 1964). The spectrophotometer shows the changes in the
color of the hemoglobin as it goes
from the oxygenated to the disoxygenated form, and the fluorometer gives a measure of the adequacy of the oxygen for the
respiratory chain . What is really being measured in this tissue is the
behavior of the source, which is
hemoglobin, in relation to that of
the sink, which is the respiratory
chain. In addition, we would like to
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have something physically located
in between-myoglobin might be
just right-but the brain does not
contain that, of course.
In the experiment an animal is
respired on different gas mixtures.
This is the independent variable
and is given on the ordinate of
Figure 12. It is, of course, a much
different scale of PO;, than in the
previous figure . Starting out at 150
mm Hg, we find a situation where
we have certain values of the currents of the photomultipliers associated with the normal tissue. The
difference between these and the
currents recorded when the animal
is completely anoxic, we give the
value of 100 for both the spectrophotometer and the fluorometer.
These values are set out on the ordinate. Now we let the animal respire on a mixture low in 0 ,, and
we will look at the hemoglobin to
see how much of it is in the oxygenated form and at the NADH to
see if it goes up, i.e., shows signs of
hypoxia. For each gas mixture you
get two points: an average tissue
PO, from the hemoglobin and an index of the adequacy of 0 , provision
to the mitochondria from the flu-

0

orescence. At about 40 mm Hg inspired, the method did not see
anything but disoxygenated hemoglobin. Actually that means less
than about 10 % oxygenated Hb,
because that is the level of confidence of these measurements. At
the same time the fluorometer recorded that the level of fluorescence had gone up only 35 % . In
other words, most of the cells were
not yet anoxic. A further decrease
in the inspired PO, finally resulted
in complete anoxia as defined by a
stable, high intensity of fluorescence.
Before we decide upon a limiting
PO, value, we should discuss one
other property of the chain . It concerns the interpretation of the increased NADH level in terms of
effects of O, lack, and it arises from
some kinetic considerations. The
real O, sink is, of course, reduced
cytochrome aa, because that is the
one that reacts with oxygen. It
turns out, again from mitochondrial
experiments in cuvettes, that when
one follows the rate of oxygen uptake as a function of the PO, one
will notice many members of the
chain at a more reduced level be-
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fore a measurable change in the
rate of oxygen uptake occurs. The
reason is a perfectly straightforward one, arising from chemical
kinetics. Since reduced aa reacts
with oxygen, the reaction rate is
proportional to the reduced aa concentration times the O, concentration. Under conditions of plentiful
0 2 , cytochrome a, is only 1 % reduced or less. There is, therefore,
an enormous capacity for cushioning the effect of low P02 on the
reaction rate. All that is needed is
an increased level of reduced aa.
This is what occurs automatically
when o. starts getting scarce, since
it will take longer before a reduced
a, molecule and an o. molecule will
collide. Over the range of hypoxia
the reduction of a3 is reflected further and further down the chain by
increased levels of reduction of the
other components. The last one to
be affected significantly will be
NAD. Roughly speaking one can
use a value of a measurably increased NADH level (10 % ) as an
end point. Here the cell reaches the
detrimental range of hypoxia.
Question: This is an intracellular
oxygen tension?
Dr. Jobsis: No. In Figure 12 we are
speaking of the P02 in the gas
mixtures. The numbers on the ordinate are oxygen tensions in the
respired air. Practically speaking
this is, of course, the crucial number. From another point of view,
however, we might want to know
the average P00 in the tissue at
which 10 % reduction of NAD
occurs in brain mitochondria. This
turns out to be, again, about 5
mm Hg; in this respect the brain
mitochondria are not greatly different from other mitochondria.
However, this number is of limited
value only. The tissue level of O.
varies, of course, depending on the
distance from capillaries. This is the
best we can say at the moment.
It is also possible to approximate from the oxygen dissociation
curve of rat hemoglobin the average capillary PO,. When N AD reduction due to hypoxia is about

10% complete, the spectrophotometric signal shows that hemoglobin is still 20 % in the oxygenated form. Assuming for the brain
tissue an average venous P02 midway between arterial and venous
blood (i.e., 70 mm during the airbreathing part of the experiment),
then 1/ 5 the difference in signal
between that level and the anoxic
one gives us, from the 0 2 saturation curve for rat hemoglobin, a
PO. of 25 mm Hg. This is again a
gross average, this time between
venous and arterial fractions. Perhaps the only usab le numbers will
come out of fluorometric experiments such as those shown in Figure 12, with or without the differential spectrophotometer trace.
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DISCUSSION

Dr. Patterson: Our discussion session now will concern this marvelous and beautifully delivered material that Dr. JObsis has given us.
I do want to introduce a gentleman
who has come at the suggestion of
Dr. Doolan, our associate dean, to
help us discuss some material that
is so basic and so difficult for a
number of us: Dr. Lutz Kiesow,
who is head of the division of molecular energetics at the Naval Medical Research Institute. I think Dr.
fobsis would like to show two slides
before the quizzing begins.
Dr. Jobsis: Thank yo u for indulging
me once more. I would like to
bring up two more things, and since
they are a little distant from the
previous focus, I thought it would
be best to wait until after the coffee
break.
I have looked at the fluorescence
of the cerebral cortex from a functional point of view, trying to relate
physiological activity with levels of
fluorescence. The activity I have
studied is paroxysmal firing induced
by strychnine or Metrazol. The experimental system was the cat with
an exposed cerebral cortex, electrodes on the pia mater and microscopic observation of fluorescence.
With this arrangement it is possible
to show that a decrease in fluorescence accompanies each burst of
epileptiform activity. A considerable amount of instrumental development has shown that this is not
an artefact caused by increased
blood vessel diameter. Monitoring
of that, as well as the administration of 10 % C02, which maximizes
vessel diameter even in rest, has
shown the reliability of this observation.
These results show that it is possible to distinguish between less active and more active physiological
conditions by the relative intensity
of the fluorescence, i.e., the relative
intensity of the metabolism. Jn
terms of the scheme of Chance
and Williams (Table 3), the extra
physiological activity tends to force
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the respiratory chain further away
from the resting level (state 4) to
the active level (state 3). The fact
that it is possible to show this in
the intact tissue is the first point I
wanted to make.
The second point concerns, perhaps, a minor issue that can be settled with the fluorescence method .
For quite a while it has been known
that epileptiform discharges are accompanied by increased metabolism
and an expansion of the cerebral
vascular bed . Because of this knowledge it has been speculated that the
end of a paroxysmal burst of high
voltage EEG activity might well be
brought about by the occurrence of
anoxia in the cortex. This I am now
able to deny. Under normal respiratory conditions, oxidations are invariably noted without a trace of a
tendency toward the increased fluorescence that is characteristic of
anoxia or hypoxia. It is possible to
produce signs of hypoxia during an
attack, but either very low gas mixtures must be administered during
the experiment or a very low rate
of artificial respiration must be
maintained. In addition, under such
conditions signs of hypoxia may
occur during an epileptiform burst
without much effect on the further
progress of the burst. Apparently
the discharges can continue for
some time without the need of continuous oxidative restoration of the
,.._, P energy stores required for recouping the loss of ions.
Dr. Worsham: Are we to understand that the length of these episodes would be the same as without
anoxia? Have you terminated the
episode by the anoxia?
Dr. Jobsis: Your understanding is
correct; the burst is not terminated
by anoxia .
Dr. Patterson: Is yo ur burst the
equivalent of a convulsive seizure?
Dr. Jobsis: Right. Usually they are
produced by strychnine and Metrazol together. It is a horrible mixture, but it's very effective.
Dr. Patterson: The floor is open for
quizzing. I think we'd like to hear

from the members of our panel
first.
Dr. Kiesow: I think what has to be
done here is to correct a few things .
First of all, there is your extremely
modest presentation of your contribution to a rather important field
of modern cell physiology. You
mentioned Britton Chance and his
almost 20-year-old efforts of analyzing and characterizing the cellular
respiratory chain and its elements.
But I think your contributions are
almost as, important as his, since
you made the step back to the physiological system. You freed yourself
from this dangling sword of Damocles of being a mitochondriac, and
you went back to as intact and as
physiological a system as you
could find . In this context I would
like to ask a question or two. One
has to realize, of course, that the
mitochondriac working with either
mitochondria, or even subunits
thereof, quite often has the advantage of less interferences caused by
cell constituents such as substrates,
coenzymes and enzymes. These are
present in intact cells but are frequently absent in mitochondria and
their subunits. The question, therefore, concerns your studies on the
fluorescence of either tissue in situ
or of muscle when excited with
light of a wavelength of 340 or 366
m,u. To what extent does this fluorescence really reflect changes of the
NADH concentration alone, and
to what extent does it reflect changes
of total of intracellular pyridine
nucleotides--NADPH as well as
NADH? I would also be interested
in data which would break down
the intracellular pyridine nucleotides of your biological materials
into the NAD and the NADP system. Furthermore, as you subdivide
the total, what are the ratios of the
reduced over the oxidized forms of
both systems?
Dr. Jobsis: This is such an invitation to expand! Dr. Kiesow has put
his finger right on a very sore spot.
I've thought a lot about it and done
some experiments. I can gladly give
some answers, although I'm sure
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they will not be as complete as he
would like to have them. This is a
very important point, and I did not
go into it only because one has to
limit a lecture in some way.
Next to NAD (nicotinamide adenine dinucleotide) there is NADP
(nicotinamide adenine dinucleotide
phosphate), which is the same
molecule with an extra phosphate
on the ribose of the adenosine. This
is also contained within the mitochondria, and when it is reduced, it
has very much the same absorption
and fluorescence properties as
NADH. It is also involved in certain mitochondrial reactions. This
is not the only possible source
of confusion, since, in addition to
mitochondrial NAD and NADP,
there is NAD, which is not in the
mitochondria but in the cytoplasm.
It is involved in glycolytic metabolism, which is, of course, highly active. I am sure this will be brought
up later on. Finally, there is another fraction of NAD in the mitochrondria which is, as far as we
know at the moment, not too directly in equilibrium with the chain.
It is not reduced directly by substrates but by a so-called reversed
flow of electrons. For this reducing
equivalents flow in the opposite direction, as usual; that means uphill
in an energy diagram. This costs
energy, of course, and high-energy
phosphates or high-energy intermediates are needed to do this. I
don't want to go too far into it. It
does not add to the present discussion. I just wanted to bring it up
to show that the picture is complex.
Let us go from the easier part
of the question to the more difficult.
The NAD in the cytoplasm is glycolytically active. This fraction does
not interchange freely with that
which is in the mitochondria. In
fact, NADH added to isolated mitochondria will not be oxidized. There
is a separate pathway for intercommunication of reducing equivalents,
but it doesn't concern us here because the problem is: Since it is
NADH and becomes alternately
oxidized and reduced, how do you

know that you're not partially measuring it? The only indications I
have are some studies on muscle,
excised muscle, where we looked
very hard for possible cytoplasmic
effects in the presence and absence
of iodoacetate. There was no contribution that we could see. This
appears puzzling, because the concentrations are very similar. Happily
for us, the fact is that NADH has
a tremendously increased fluores.cence efficiency when in mitochondria. It fluoresces. up to 20 times
more intensely per concentration
unit than it does in solution or,
apparently, in the cytoplasm. This
is the reason why our signal is derived, as far as I can see, from
mitochondrial NADH.
NADPH is a different problem.
It is involved in various other biochemical steps, and it is also oxidizab le and reducible and should
contribute absolutely the same type
of signal. There are two points that
save the day. First, there happens
to be very little NADP present
compared to NAD. Second, both
Dr. Chance and I, independentlyDr. Chance for liver and I for brain
-have analyzed biochemically for
NADP. In my case, the experiments were closely related to the
fluorescence experiments. We measured the fluorescence in one spot.
We produced a maximal decrease
in fluorescence with strychnine administered i. v. and took a sample
from the other hemisphere. In other
words, in the middle of a strychnine
attack we froze a piece of tissue
and removed it. Next we let the
brain go fully anoxic by apnea and
took a second sample right in and
around the point of optical observation. Then we analyzed with enzymatic methods and compared
left side against right side, anoxic
against oxidized. It turns out that
the NADPH concentration doesn't
change in such an experiment,
while the NADH does and, incidentally, shows a good correlation
with the increase in fluorescence.
So, we're pretty sure that NADPH
does not interfere. Dr. Chance has

been able to pick up some signs of
an effect in the liver but with slow
kinetics. In other words, he has
seen NADPH changes, but they
were at a different rate than the
fluorescence and the NADH
changes.
In conclusion, then , we appear
to be rather safe. However, there
remains the cytoplasmic fraction of
NADH. We cannot analyze for it
differentially. It is probably also
affected by some of the same
factors that affect electron transport.
The only reassurance is the fact
that, in various other preparations
such as muscle, it has been shown
that its quantum efficiency of fluorescence is some 10 to 20 times less
than that of NADH associated with
the oxidative phosphorylation function of the respiratory chain .. That
is the answer, I think.
Dr. Kiesow: You were referring to
the problem of energy-linked reversal of the electron transport. If
I remember correctly, Chance recently published a paper where he
demonstrates that this step is affected by hyperbaric oxygen. He
claims that this effect is not due to
an increased rate of autoxidation
of reduced flavoprotein , but is due
to a direct effect of hyperbaric
oxygen on this reversal of the electron transfer. What would you consider to be hyperbaric conditions
here; hyperbaric in regard to oxygen, that is?
Dr. Jobsis: If you want a hard
number, I'm sure I cannot give it
to you. I think anything that produces a level higher than about
30 to 40 mm Hg-averaged tissue
P0 2 is probably hyperbaric. That's
the range for which you need a
hyperbaric chamber. But I'm not
too well acquainted with hyperbaric
work. The experiment that you
refer to was the following. When
mitochondria are exposed to high
oxygen pressure (5 to 12 atmospheres) it appears that one inhibits,
the reduction of the N AD fraction
which receives its reducing equivalents by reversed electron flow (the
pathway that goes from succinate
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via fiavoproteins to NAD). Exposure to hyperbaric oxygen prevents NAD reduction upon the
addition of succinate. This is suggestively linked to some measurements of Sanders, Woodhall and
their group in which they have
shown that very high levels of succinate in the blood protect against
cerebral damage by hyperbaric oxygen. (A. P. Sanders, I. H. Hall,
P. J. Cavanaugh and B. Woodhall.
In Proceedings 3rd International
Conference on Hyperbaric Medicine. I. W. Brown, Jr. and B . G .
Cox (eds.). Nat. Acad. Sci.-Nat.
Res. Council, Publ. No. 1404, pp.
73-82, 1966). The suggestive implication is that a tremendous
amount of succinate-and these are
really enormous levels they are
working with-produces a protective effect by partially overcoming
this inhibition. However, I don't
believe that Chance has been able
to verify this by direct observation.
Until now, regardless of the dose
of administered succinate, he just
hasn't seen it.
Dr. Robin: Dr. JObsis, I would like
to join my colleagues in thanking
you for this superb discussion, and
I won't end that compliment by
using a harpoon. I should like to
ask you a question. It's a self-serving one, because after you answer
it, I would like to make a comment,
regardless of how you answer the
question. I think that one of the
purposes of a conference like this
is to highlight matters that are of
potentially great interest for the
future in the areas that are being
discussed. The question that I
would like to ask is : Are there data
available concerning whether the
peroxidase pathways, the non-cytochrome pathways involving energy
generation, are linked, on one hand,
with ATP generation and, on the
other hand, with acetyl Co-A as
an intermediary? In other words,
how closely are they linked to the
usual kind of oxidative phosphorylation?
Dr. Ji:ibsis: Well, I'm very glad that
you gave me a choice of any
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answer, because I am not too well
acquainted with these systems. I
have looked into this matter a bit,
since I worried that these reactions
might affect the mitochondrial reaction. Being a rather pragmatic experimentalist, I immediately stopped
going into further details when I
found that they did not seem to
hinder my system of measurement.
Hence, I would really like to hear
your comments.
Dr. Robin: What I should like to
indicate is that the area of noncytochrome-linked energy generation is, in my opinion, a potentially
very important one and that there
are at least two physiological circumstances that I know of in which
the possibility of non-cytochromelinked energy generation has been
raised. With your permission, Dr.
JObsis, I might indicate these.
One system is the alveolar macrophage, which is being extensively
investigated by a number of
workers, including my colleague,
Dr. Bernard Gee. This fits in with
this type of audience, because there
are lung types and heart types, and
one of the important functions of
the alveolar macrophage, of course,
is to phagocytize inert, dead bacteria,
and living bacteria. Almost certainly
this is an endergonic, an energy-requiring process, and one can establish this by several lines of evidence,
but one of the most striking lines
of evidence is that, if you measure
the oxygen consumption of the
alveolar macrophage in its resting
state and then let it gobble up dead
bacteria, there is a brisk increase
in oxygen consumption .. Now, if
you manipulate this system by partially inhibiting cytochrome b by
using antimycin, or you use cyanide
and partially inhibit aa so that the
cells are still living, there is obviously a profound decrease in oxygen consumption, but there is no
effect on phagocytosis. There is evidence which indicates that, although
the general level of oxygen consumption is decreased in these cells,
there is still, at this reduced oxygen
consumption, an increase under

circumstances of phagocytosis. Obviously, the easiest way to reconcile these data would be to say that
there must be another energy link,
another oxygen-requiring process,
which does not involve the respiratory chain.
The second system is the nucleated red cell of the shark, and
the findings to be discussed are
probably characteristic of most nucleated red cells. Unlike mammalian
red cells, nucleated red cells are
brisk oxygen consumers. One can
measure oxygen consumption in
these cells by standard methods.
One of the important energy-requiring processes in red cells generally is the process by which
sodium is transported from the inside of the red cell to the plasma
against an electrochemical gradient. If one is interested in energetics, one is, of course, anxious to
quantitate the metabolic costs of
performing this transport work.
(Dr. Ji:ibsis's colleague, Dr. Tosteson has spent a good part of his
professional life in this area.) Now,
if you take this cell and inhibit anaerobic glycolysis by using one of
the standard inhibitors, there will
be a marked decrease in sodium
transport. So, presumably, the
major energy source for this transport process is anaerobic glycolysis.
If you take large doses of cyanide
and you inhibit the respiratory
chain, you get no change in transport. This raises an important
question, because presumably both
respiratory chain activity and anaerobic glycolysis result in ATP generation. How can the cell distinguish between the ATP which is
being generated oxidatively, which
is not available for transport, and
the ATP that is being generated by
anaerobic glycolysis? Even more interesting than this is the finding
that exposure of cells to nitrogen
leads to a decrease in transport
rate. I can summarize these results
as follows. Let us assume the normal sodium transport rate is 15
mEq Na+/kg red cell H.O per hour,
transported from the inside of the
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red cell to the outside. If one stops
anaerobic glycolysis, the transport
rate falls to 5 mEq Na•/kg red cell
H.O. If one cuts out the respiratory
transport chain by either antimycin
or cyanide, the transport rate remains at 15 mEq Na•/kg red cell
H.O. On the other hand, if one decreases oxygen availablity by exposing the cells to 100 % nitrogen,
the transport rate falls to, say, 8
mEq Na•/kg red cell H.O. This
suggests that some aliquot of energy
cost for this process is being mediated by non-cytochrome oxygen
consumption, and the sum total of
this is, then , as I said at the beginning, that non-cytochrome-mediated energy generation is probably
a much more important field than
has been appreciated in the past
and may be a "hot" area of work
in the future . Would you comment
on this?
Dr. Jobsis: I am very glad to hear
these data. For the last half year
a graduate student, Mr. Hersey, and
I have been looking for these kinds
of systems. I guess we will just have
to go to the Caribbean and catch a
shark or two.
I would like to point out one
thing. Earlier in my presentation I
talked about autoxidative flavoproteins, and I mentioned that there
is no known energy-saving step.
High energy phosphate is definitely
not being formed. This could really
say something else again, namely
that energy utilization, although not
mediated by ATP, might perhaps
be a direct function of the membrane components without the intervention of ATP. It is a most
important point. Altogether, I'm
very glad indeed that this gives us
a good excuse to go to the Caribbean around Christmas.
Dr. Carter: I have just three short
questions: 1) Does the fluorescence
generation result in any significant
temperature change of the tissue?
2) Have you thought of the possibility of using a fiber optic to come
beneath to limit your depth? We've
had some success in using fiber optics in kidney, in other words, pok-

ing in and coming up. It sounds a
little drastic, but remember that
these penetrations are very small,
and it's conceivable that you would
have a known depth of un-damaged
kidney and brain under these circumstances. And finally, 3) Could
fluorescence possibly be used as a
measurement of blood flow? I
should certainly like to hear a little
more about why fluorescence is
related to blood flow. Specifically,
we would be very much interested
in measuring blood flow on the
surface of the kidney.
Dr. Patterson: If I remember correctly, you actually said you corrected the fluorescence for changes
in blood flow, and I was fascinated
by the possibility that this technique might be used to measure
blood flow.
Dr. Jobsis: I didn't measure it; I
just got rid of it.
Your first point, Dr. Carter, was
about the temperature. We have a
highly filtered light beam. Practically all infrared is eliminated. In
addition, we have measured the
temperature by using a small thermistor, enclosing it in a drop of saline
and putting that on top of the cortex. The rate of heating is insignificant as long as the blood supply is
intact. This carries heat away very
effectively. However, if you stop
the circulation, in a dead cat, for
example, you have a slight rise in
temperature; but there is greater
danger in direct radiation damage
of the tissue. We don't know the
mechanism, but it is signified by
pinprick hematomas appearing in
the optical field. This is much worse
for the shorter wavelengths. The
366 mµ, line is a good compromise
between effectiveness of NADH excitation and relative lack of damage.
The second point was about the
fiber optics. First of all, I didn't
know one could go down to that
small dimension. I'd love to talk
instrumentation with you for a
while after the meeting. This certainly sounds very exciting. There
is a problem which I'm sure will
be solved in the near future, and

that is that the last time I looked
into fiber optics, the index of refraction of available materials was such
that the wavelengths of light between 300 and 400 mµ, were not
transmitted well by the fiber optics.
I'm sure that something can be
done about it. I'm not sure that I'm
the right person to try to do it,
though.
Comment from audience: There
are plastic ones now available.
Dr. Jobsis: They are very bad at the
moment, because plastics have some
absorption in that region. For small
thicknesses it is no problem. In fact,
all my cuvettes and muscle chambers are made of lucite, but they
are limited to about a millimeter
of thickness in the light path. If
you're going through fiber optics,
however, you are working with centimeters.
Comment from Audience: But
you've got too much light, anyway,
you said.
Dr. Jobsis: Well, that's relative. An
additional problem is a faint blue
fluorescence excited by 366 m µ,.
Now, the final point about blood
flow. This was very much a headache, especially changes of blood
content in the field. Hemoglobin
will diminish the fluorescence in
two ways. First, it will absorb excitation light, and then it will absorb the emitted fluorescent light.
When light penetrates a red cell ,
practically all the 366 mµ, light is
absorbed, and almost the same
occurs for the fluorescence. Therefore, the problem that you face is
the following. You are looking
down on an optical field on the
surface of the tissue. Through the
field run capillaries, venules, and
arterioles. By eye, it looks very
much like a network of black
threads running through a blue
background. Lateral and depth
resolution are not sufficient to avoid
anything but the very largest vessels. When something increases the
metabolic activity, blood flow increases either by an opening up of
more capillaries or by distention of
vessels. The effective field from
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which you are recording decreases,
therefore, every time you have an
increased distention of the vessels.
Excitation light is scattered in
the tissue, and some of it is picked
up by the objective. This fraction is
affected by changes in blood volume
in much the same way as the
fluorescence . With appropriate optical beam-splitters and filters, it
can be measured and provides a
control for the light absorption
changes affecting the fluorescence.
I have often wondered whether
these changes in the scattered 366
mµ, light might not provide the
basis for a useful means of monitoring blood flow parameters.
Dr. Patterson: You are actually not
correcting the change of blood
flow, but the changes in blood
volume.

Dr. Jobsis: Correct.
Dr. Worsham: It is really farther
removed than that. What you are
really correcting is the amount of
hemoglobin in the field.
Dr. Jobsis: Yes. You see more
hemoglobin in the field due to distention of the vessels. Incidentally,
the response time is quite good.
The time resolution is in the neighborhood of two seconds.
Dr. Patterson: We would now like
to throw this program open to
general questioning of our distinguished speakers.
Dr. Huf: I have two questions.
The first one is related to the problem which the first discussant raised
about the importance of specific
factors located outside of the mitochondria. I am now raising the
question of the importance of unspecific factors. Take the muscle,
for instance. When you throw the
muscle into activity, you are bound
to get all kinds of unspecific
changes, membrane changes, protein contraction, pH changes, osmotic changes. Hence, you don't
really look at a specific system, let's
say the B system, in the same physicochemical environment. To what
extent do unspecific factors, the
kind mentioned, affect at least the
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transient changes and, perhaps,
steady-state changes as well?
The second question deals with
the point which you made about
the significance of the rate at which
metabolites enter into cells. 'Vhen
you come into the region of very
low oxygen tension, would it be
useful to consider as a limiting
factor the rate of oxygen supply?
You do have a high oxygen diffusion coefficient, but you have reduced the oxygen gradient to practically nothing; so it comes, as it
were, to a competition between
limiting factors. You may have a
high concentration of substrate of
low mobility, or you may have
a low concentration of oxygen
which bas a high diffusion coefficient. So, what is limiting?
Dr. Jobsis: Let us start with the
second question first. We are pretty
sure that oxygen is limiting at very
low P02 levels; say, less than 0.5
mm Hg. Above that there is a large
region in which we can not decide
what the limiting factor is. With
tissues, and especially tissue slices,
it probably would be the low P02
due to diffusion path lengths. There
is no telling when this is the case
unless you do an experiment with
varying P02 levels. The uncertainty
about the diffusion is, of course,
part of all considerations of this
nature. Fortunately, most cell membranes do not exclude either 0 2 or
C02, so no significant new barriers
are erected.
There is one aspect of the control of a sequence of reactions that
escapes the uninitiated. I think Dr.
Worsham has some very significant
things to say about this. The problem is that most of our kinetic
thinking is derived from enzymes
in a cuvette or a test-tube. We can
throw a substrate in and measure
how fast it is converted. %en you
have added an insufficient amount
of substrate and you see a decrease in the rate, you know immediately and quite correctly that
your substrate concentration has
limited the velocity. However, in a
mitochondrial system and even

much more so in cells, there is a
very complex situation with many
control points. Take, for instance,
the glycolytic chain. There is
usually plenty of glycogen, yet
lactate formation does not proceed maximally. Here there may be
as many as six different control
points. In the mitochondrial system
itself there are three already in
oxidative phosphorylation. There is
not one primary control point; each
one of the sites of oxidative phosphorylation provides control, and
the rate becomes different if you
take just one away. There is, therefore, a very complex interaction,
complex enough to boggle the mind
really. One needs to use computers
to represent all the individual rates
and their influences on each other.
However, at very low oxygen levels,
I think it is. warranted to say oxygen is limiting and, of course, in a
tissue, oxygen diffusion is one of
the limiting factors.
As to your first point, yes, there
is a tremendous amount of difficulty
with non-specific changes. Just
fro m an instrumental point of view,
it is difficult, because when a muscle contracts, it scatters light quite
differently than when it is in the
resting condition. The double-beam
method is necessary to overcome
this. For a first approximation this
is all right. However, light of different wavelengths is not scattered
equally. Low wavelengths are scattered more intensely than high
wavelengths. %en your expected
absorption is very small , this will
get in the way. Then you must use
two reference wavelengths, straddling the wavelength that you want
to measure. In other words, if I
want to measure 550 m 1.t, I use as
reference 540 and 560 mµ,, thereby
getting rid of most of the wavelength specific effect. However, the
increase in scatter is not linear with
the wavelength; it is a power function, and one has to correct also
for that.
Dr. Worsham: It depends on the
direction of scattering, too, unless
you have a spherical molecule.
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Dr. JObsis: That doesn't bother us
too much, because that effect is
not too wavelength specific. It's a
very correct point, but pragmatically we don't worry about it much.
Now, your final point. There are
not only instrumental difficulties,
but physiochemically a contracted
muscle is a different system. We can
o nly rely at this point on changes
we can observe in mitochondria in
cuvettes and compare them to those
in the tissue. It turns out that we
don't get too many differences by
changing any extracellular parameters. The functions we are studying are rather insensititive to pH.
Only large pH changes show anything, and I have some data on
changes in intracellular pH relevant
to this.
Dr. Huf: What are large changes of
pH?
Dr. JObsis: .2 of pH unit, or something close to that.
Dr. Huf: How much does the pH
change when the muscle contracts?
Dr. JObsis: I have looked at the
pH changes after small amounts of
contractile activity and before glycolysis is stimulated. During glycolysis really large changes occur in
the internal pH. But keeping away
from lactic acid formation as best
you can, pH changes occur as a
result of a single twitch, which are
in the neighborhood of .05 pH
unit. Other people have looked at
this long ago and found the same.
Then there may be osmotic
changes. They are very unpleasant
when they are large. It looks, however, as if that does not occur in
the muscle cell, with the possible
exception of some increased osmotic pressure due to long term
a noxia. In general, we have covered
the difficulties pragmatically, but we
certainly have not stopped trying
to study each for its own worth.
Question from the Audience: At
what level of hypoxia does this
reaction of strychnine disappear
completely?
Dr. Jobsis: You mean an increased
EEG? I have not tried that. The
spontaneous EEG disappears some-

where in the neighborhood of
breathing 3 % to 5 % oxygen, at
least in our blissfully anesthetized
animals. I really don't know at what
level of PO;, the paroxysmal, strychnine-induced EEG stops.
Dr. Kontos: I was wondering whether your method is fast enough to
observe any rapid spontaneous
changes in living muscle, for instance, in response to changes in
blood flow. The records you have
shown before you interfered with
some particular intervention looked
pretty close to straight lines. Is this
true?
Dr. JObsis: These muscle records
were from excised muscle, so we
avoided that problem. Dr. Stainsby,
Dr. Renkin and I have planned to
investigate that a bit later this fall.
Dr. Renkin is specifically interested
because of possible changes in capillary distribution, distribution of
open and closed capillaries. Dr.
Stainsby is interested in the relation between lactate production
during exercise and possible hypoxia in muscles doing different
kinds of work. I am just interested.
Dr. Worsham: I want to make a
comment, if I may, but first I want
to ask a question. I'd like to ask
how well we know the characteristics of each step along this cytochrome chain. Do we know the
rate constants and the Michaelis
enzyme constants all the way along
for each step?
Dr. Jobsis: We do not know
enough, but we know approximately. You can observe each component of the respiratory chain with
the exception of cytochrome c,.
Many of the rate constants are
well determined, although one always wishes for better.
Dr. Worsham: I'd like to suggest
that perhaps the time has come for
you to join forces with the theorists,
if you classify yourself as a pragmatist, and go ahead and try to
simulate your system from the
known in vi tro characteristics of
these various steps. The best thing
you could hope for is that your
computer simulation, a model built

up from the known isolated characteristics, would then agree with
what you see in some of your experiments. I am impressed with how
well you have cut out a lot of
complications. This is always the
place to begin for a good theoretical approach; in fact, you think like
a theorist and work like an experimentalist, but you have done the
best experimental job of getting a
real simple system to study. Perhaps you have a chance now of
building a model, putting it on to a
fairly modest computer and trying
to see if your model does agree with
what you have observed. One needs
theory to program an analog computer to simulate the reactions that
occur in a metabolic pathway. D r.
JObsis has well indicated the nature
of the problem. He wiggles the
oxygen concentration at one end of
the chain, and he wants to know
what happens to the NADH rate
turnover at the other end of the
chain. This problem is not easy to
solve.
Dr. Patterson: Well, you are teaching kinetics of reversible processes,
and a lot of these are irreversible.
Dr. Worsham: That's not true. The
difference is that the metabolic systems in the animals we have studied
have no beginning. That's really the
difference. There's no C. in the
processes that you study. There's a
steady state you can think of, a
metabolic steady state; you perturb
this, and it goes to another steady
state. What I'm saying is that the
kinetics you think of as pot kinetics
are quite different from the kinetics
of steady-state metabolic path rates
to add itional steady states.
Dr. Kiesow: I completely agree that
the problem here is the flow kinetics
-rather the pot kinetics-and I
was just wondering, since it obviously is a question of measuring
the intracellular oxygen concentration with an indicator as close as
possible to oxygen, whether you
have ever tossed around the thought
of using the photodissociation of
the carbon monoxide complex of a3
as an indicator for intracellular
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oxygen? The second question: Although the autoxidation contributes
to only 10% of the total oxygen
consumption, it should have, and
it does have, the characteristic of
being much more proportional to
the partial pressure of oxygen than
this a,, which is very low saturation
pressure. Isn't it possible, perhaps,
also to use the state of the redox
system at the level of flavoprotein
as an indicator for intracellular
oxygen pressure based on the autoxidation where the rest of the
chain is hooked off by either an
inhibitor, antimycin A, or cyanide
or carbon monoxide?
Dr. Jobsis: Actually I'd like to go
in reverse order, which is not too
pleasant, but I don't think that
would be an insurmountable problem. From the specific to the more
general, I have never thought of
using the autoxidative fiavoproteins as indicators. However, it
sounds like a very, very good suggestion indeed if we can be sure we
have blocked the other fiavoproteins. We need cyanide. That can
be solved. A bit of difficulty lies in
trying to get an index to fiavoproteins. They have rather weakly differentiated spectra. However, a colleague of all of us in this field, D r.
Jose Ramirez of Mexico City, who
unfortunately died in a car accident, had, at the time of his death,
completed a system of fluorescence
measurements of fiavoprotein that
he thought was very promising. I
am sorry to say that progress on
this ceased with his death ..
As for the remark of Dr. Worsham, I really wanted him to come
up with this very important point
that we are not working in the
same type of chemical kinetics as
that so often found in textbooks.
Dr. Worsham: You mean they
taught you the wrong thing?
Dr. Jobsis: Yes, for this purpose it
is wrong. Recently, however, the
physical chemists have been getting more interested in such systems. I am glad that they are correcting themselves. I should be
more humble at this point, because
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I am a rank amateur in computer
work, but I love to play around
with computers and sometimes have
to tear myself away from the analog
because it's so wonderfully neat.
You put in the values, the curves
come out beautifully, and you
think, "Now I'm doing science!"
Of course, you're not doing science
at all, because a dirty experiment is
really what science is made of. To
interpret a dirty experiment, however, you need an analog computer.
Although I've done a bit of this
sort of work, this is being done very
intensively at the Johnson Foundation by a whole group of computer
people. In fact, they have made a
system, starting out with glucose
and some other substrates in glycolysis, taking in the whole respiratory chain and taking ATP consumer reactions into account, also.
Dr. Worsham: Have you tried their
model to simulate your experiments?
Dr. Jobsis: No. I, myself, have not
played with the analog computer in
this system. I have played with it
in the interpretation of energy turnover in muscle contraction.
Dr. Worsham: Why don't you go
to their computer and say, "Let
me ...
Dr. Jobsis: Well, they are doing
this, so I am just waiting for them
to do it. Of course, sometimes they
don't ask the right questions.
Dr. Worsham: That's where they
need you.
D r. Jobsis: Yes, but you'll have to
convince them of that. There are
two fe llows, each with his own
group; one working with an analog
computer group, the other with a
digital computer group. By the way,
I think they have purposely been
put next to each other to produce
some healthy competition.
D r. Worsham: By the way, your
comment was excellent. Thomas
Huxley said, "The great tragedy of
modern science is the slaying of a
beautiful theory by an ugly fact."
Dr. Robin: Two comments. Dr.
JObsis, maybe this afternoon I can
provide you with an animal in

which you can completely knock
out a, and have both the animal
and the brain survive for at least
one to two weeks. Secondly, since
we're being philosophical and comparing the differences between how
things work in a complicated cell
and a complicated animal, macromolecules and ions being put in
a test-tube with some water and
shaken up together, I think the
problem is even deeper than that.
We have no c.. In many kinetic
processes the kinetic changes that
take place depend on the previous
point along the curve, and, therefore, if we are describing any of
these multicomplicated steps, we
have to describe them each in terms
of a family, at best. Consequently,
I am not sure you've been teaching
the wrong kind of physical chemistry. I am not sure that the right
kind of physical chemistry yet
exists which can accurately define
these kinds of systems, and, therefore, what we try to do is try to
make the best approximation we
can with the method and thinking
that is available until, hopefully,
somebody comes along with a
physical-chemical-theoretical structure which can deal with variables
which change so rapidly.
Dr. Patterson: Haven't people like
Dr. Prigogine, working with thermodynamics of irreversible processes, and others studying the irreversible processes helped somewhat
in this area?
Dr. Robin: Yes, although I think
you are referring to something that
is a little bit different. The difference between reversible and irreversible thermodynamics is involved in your question. The basic
assumption that is made in classical thermodynamics is that you deal
with equilibria, and, of course, in
living systems there are no equilibria. The consequences of not having equilibria are that the best you
can deal with are steady states or
quasi-steady states, and the general equations that apply to each of
these two different approaches are
quite different.

